Playback speed
10 seconds
ESMO 2023 Insights: "REGOMA-OS Study Analyzing Regorafenib Efficacy & Safety in Recurrent Glioblastoma Patients"
By
Insights from 2023 ESMO Annual Meeting
FEATURING
Giuseppe Lombardi
By
Insights from 2023 ESMO Annual Meeting
FEATURING
Giuseppe Lombardi
109 views
November 17, 2023
Login to view comments.
Click here to Login